Judiciary Committee Passes Cicilline Bill to Lower Prescription Drug Costs

Tuesday, April 30, 2019

WASHINGTON – The House Judiciary Committee overwhelmingly approved Congressman David N. Cicilline’s (RI-01) bipartisan proposal to drive down the cost of prescription drugs today.


The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (H.R. 965) will prohibit big pharmaceutical companies from engaging in anti-competitive conduct to prevent generic versions of prescription drugs from entering the marketplace.


“I have heard from too many Rhode Islanders who work hard and play by the rules, but still have a hard time affording the cost of prescription drugs,” said Cicilline. “I’m proud that the Judiciary Committee is providing much-needed relief to lower costs for working people. Once this bill passes the House, Senator McConnell should take it up without delay.”


The CREATES Act is co-sponsored by House Judiciary Committee Chairman Jerrold Nadler (NY-10) and Republican Congressman James Sensenbrenner (WI-05). The Congressional Budget Office (CBO) projects that Cicilline’s proposal will save taxpayers $3.9 billion. According to the Federal Trade Commission (FTC), the inclusion of generic drugs in the marketplace can reduce prices for consumers by more than 85% off the brand-name price.


The CREATES Act now awaits further consideration by the full U.S. House.


DNC Twitter